PIH has treated more than 10,500 people with multidrug-resistant TB in Peru and achieved cure rates greater than 75 percent—some of the highest in the world. This work has inspired major changes in national and global health policies and overturned assumptions that the drug regimen for the disease is too expensive and too complicated to succeed in poor communities.